Advertisement

Topics

Pharmacokinetics in Extracorporeal Membrane Oxygenation

2018-12-11 02:28:16 | BioPortfolio

Published on BioPortfolio: 2018-12-11T02:28:16-0500

Clinical Trials [513 Associated Clinical Trials listed on BioPortfolio]

Hemoperfusion in Extracorporeal Membrane Oxygenation (ECMO) Patients

Extracorporeal membrane oxygenation (ECMO) is a temporary mechanical circulatory support device for cardiogenic shock (CS) patients. During extracorporeal membrane oxygenation (ECMO) suppo...

Extracorporeal Membrane Oxygenation (ECMO)

Since the 1970s, extracorporeal membrane oxygenation (ECMO) support has been used to support gas exchange for children with severe acute respiratory failure who fail mechanical ventilation...

Extracorporeal Membrane Oxygenation: Blood Cells

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outc...

Costs of the Patient's Stay Under ExtraCorporeal Membrane Oxygenation From the Hospital Point of View: a Pilot Study at the Rennes University Hospital Center

The objective of this study is to determine the average cost of stay of a patient supported by ExtraCorporeal Membrane Oxygenation from the point of view of the hospital facility, during t...

Population Pharmacokinetics of Teicoplanin, Levofloxacin, Piperacillin/Tazobactam, Remifentanil, Sufentanil, Clopidogrel, Ticagrelor During Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Extracorporeal membrane oxygenation (ECMO) is the device which increases the supply of oxygen to the body tissues in vitro and to assist in heart and lung function. Venoarterial (VA) ECMO ...

PubMed Articles [4401 Associated PubMed Articles listed on BioPortfolio]

Using thermochromism to simulate blood oxygenation in extracorporeal membrane oxygenation.

Extracorporeal membrane oxygenation (ECMO) training programs employ real ECMO components, causing them to be extremely expensive while offering little realism in terms of blood oxygenation and pressur...

A Single-Center Experience of 900 Inter-Hospital Transports on Extracorporeal Membrane Oxygenation.

The dawning of the extracorporeal membrane oxygenation (ECMO)-2 era, with the potential of decentralizing ECMO treatment, has stressed the need for research into the safety of ECMO transportations. Th...

Extracorporeal membrane oxygenation in Thoracic Surgery - Lung Transplantation.

Extracorporeal membrane oxygenation (ECMO) has become a routine method in thoracic surgery. Recent developments in lung transplantation have led to its widespread acceptance. Firstly, ECMO is increasi...

Insufficient left ventricular unloading after extracorporeal membrane oxygenation : A case-series observational study.

Extracorporeal membrane oxygenation (ECMO) is a method widely used to support circulation in patients with fulminant myocarditis (FM). However, a common complication associated with ECMO is left ven...

Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis.

The impact of antithrombin replacement during extracorporeal membrane oxygenation (ECMO) in adults remains unclear. This work comprises a survey, showing that antithrombin is routinely supplemented in...

Medical and Biotech [MESH] Definitions

Application of a life support system that circulates the blood through an oxygenating system, which may consist of a pump, a membrane oxygenator, and a heat exchanger. Examples of its use are to assist victims of smoke inhalation injury, respiratory failure, and cardiac failure.

Deficient oxygenation of FETAL BLOOD.

A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)

A member of the vesicle-associated membrane protein family involved in the MEMBRANE FUSION of TRANSPORT VESICLES to their target membrane.

The entering of cells by viruses following VIRUS ATTACHMENT. This is achieved by ENDOCYTOSIS, by direct MEMBRANE FUSION of the viral membrane with the CELL MEMBRANE, or by translocation of the whole virus across the cell membrane.

More From BioPortfolio on "Pharmacokinetics in Extracorporeal Membrane Oxygenation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial